Skip to content
Head to head

Stryker Corp vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: SYK · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

SYK -13.2%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield.
SYKABT
Snapshot
SectorMedical DevicesMedical Devices
Last price310.00103.00
Change today-0.98%-0.84%
1-year return-13.3%-15.4%
Market cap$118.01B$178.39B
52-week range266.16 – 386.0280.89 – 126.70
Valuation
P/E (TTM)33.0138.29
P/E percentile, own 5-yr range4th99th
P/B5.033.50
Dividend yield1.14%2.41%
Profitability & growth
EPS (TTM)8.403.72
Net profit (TTM)$3.20B$6.44B
Revenue (TTM)$26.30B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+7.6%+14.5%
Gross margin65.3%56.9%
Operating margin21.8%13.8%
Net margin13.8%9.7%
Free cash flow (TTM)$4.57B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership81.3%81.2%
Insider activity (12mo)13 buy / 31 sell36 buy / 12 sell
Short interest (% of float)1.7%1.1%
Analyst consensus86% buy / 14% hold (21)93% buy / 7% hold (15)
Analyst price target$344 (+11%)$122 (+18%)
StockVane view
StockVane Quant RatingD (25)D (22)
Company
Employees56,000115,000
Founded19461900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.